Meanwhile, ELISA analysis showed that 4-OI treatment significantly reduced levels of pro-inflammatory cytokines (IL-1β and IL-6) in both colitis tissues and serum (Fig. 6j-k). The gene discussed is IL1B; the disease is colitis.